When it comes to which of the two biotech stocks with COVID-19 vaccine candidates focused on in today’s article is the better pick going forward, especially for aggressive investors, the answer may come down to factors other than those particular vaccines. For the case for each of these two coronavirus-focused biotech stocks – both of which have skyrocketed in recent months even though one has received far more attention than the other – and which may be the better pick right now (and why), CLICK HERE.